Palvella Therapeutics (PI6) Financial Statements

0 Followers

Palvella Therapeutics Financial Overview

Palvella Therapeutics's market cap is currently €1.56B. The company's EPS TTM is €-0.924144822; its P/E ratio is -28.23; Palvella Therapeutics is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 25.90M	$ 31.42M
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 23.12M	$ 29.05M
Operating Income	$ -38.60M	$ -14.10M	$ -11.87M	$ -43.47M	$ -51.83M
EBITDA	$ -35.90M	$ -13.12M	$ 18.69M	$ -30.50M	$ -43.37M
Net Income	$ -41.72M	$ -17.43M	$ 18.69M	$ -33.28M	$ -45.74M
Balance Sheet
Cash & Short-Term Investments	$ 57.98M	$ 83.60M	$ 7.35M	$ 16.05M	$ 117.76M
Total Assets	$ 59.56M	$ 88.23M	$ 7.55M	$ 16.52M	$ 153.56M
Total Debt	$ 633.00K	$ 0.00	$ 0.00	$ 0.00	$ 14.89M
Net Debt	$ -57.35M	$ -83.60M	$ -7.35M	$ -16.05M	$ -102.87M
Total Liabilities	$ 31.58M	$ 25.63M	$ 11.43M	$ 39.70M	$ 102.81M
Stockholders' Equity	$ 27.98M	$ 62.61M	$ -3.88M	$ -23.17M	$ 50.76M
Cash Flow
Free Cash Flow	$ -25.01M	$ -10.84M	$ -13.70M	$ -14.84M	$ -8.61M
Operating Cash Flow	$ -25.01M	$ -10.84M	$ -13.70M	$ -14.84M	$ -7.66M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ -949.00K
Financing Cash Flow	$ -660.00K	$ 87.09M	$ 5.00M	$ 9.57M	$ 59.13M

Currency in USD

Palvella Therapeutics Earnings and Revenue History

Income Statement >

Palvella Therapeutics Debt to Assets

Balance Sheet >

Palvella Therapeutics Cash Flow

Cash Flow >

Palvella Therapeutics Forecast EPS vs Actual EPS

Earnings >